Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 472 participants.
Also called NCT06742567
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 472 participants
- Registry
-
NCT06742567
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Recruiting
Technical summary
Registry record NCT06742567. Randomized; single masking; primary purpose prevention. Start 2024-12-02 (actual); primary completion 2025-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction
- Acronym
- POTAMI
- Condition
- Acute Myocardial Infarction of Anterior Wall
- Condition
- Left Ventricular Thrombus
- Condition
- Prophylaxis
- Intervention (Drug)
- Apixaban 2.5 MG PO BID
- Intervention (Drug)
- Control (Standard treatment)
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
Record details
- Record id
cardio:ct-nct06742567- Content hash
9c5c34c4a624c8c90b91a78fa796020d31bbc63f314c58765b8245c580771130